Companies: 10,795·Total market cap: $144.5T
Check-Cap Ltd.

Check-Cap Ltd.

CHEKNASDAQHealthcare
$1.86
+$0.03(+1.64%)
Market Cap$10882685
P/E Ratio
52W High$3.13
52W Low$0.56

Check-Cap Ltd.(CHEK)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

chek · 股价预测 · 6 位分析师(近3月)· FMP · 更新于 2025年11月17日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

SellBuy

Buy

6 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
2
Sell
0
Strong Sell
0
合计: 6 · 买入占比: 66.7%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.16

Check-Cap Ltd.(CHEK)的分析师共识为 Buy,基于过去 3 个月内 6 位华尔街分析师的评级。CHEK 的 12 个月平均目标价为 $0.00,相对当前价 $3.16 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$3.160.00%

1-day model range: $3.15–$3.17. Peak: $3.17 (+0.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

0%100%0%
0Buy
14Neutral
0Sell
RSI (14)50.0Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · CHEK · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$0.00NEUTRAL
MA 10$0.00NEUTRAL
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $CHEK · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.00NEUTRAL
EMA 10$0.00NEUTRAL
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $CHEK · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2023-06-07
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2023-05-15
Maintains
BuyBuy
HC Wainwright & Co.2023-04-05
Maintains
BuyBuy
HC Wainwright & Co.2021-08-09
Maintains
BuyBuy
Dawson James2021-03-17
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2021-03-16
Maintains
BuyBuy
HC Wainwright & Co.2020-11-19
Maintains
BuyBuy
H.C. Wainwright2020-04-24
Maintains
BuyBuy
Dougherty2019-02-05
Maintains
BuyBuy
HC Wainwright & Co.2018-05-23
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Check-Cap Ltd. (CHEK) stock. Of the recent 13 rating actions, 0 were upgrades and 2 were downgrades. 6 analysts currently cover CHEK.

分析师推荐趋势

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

CHEK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$2M

↓ 7.1% YoY

Revenue Next Year

$76M

↑ 3447.1% YoY

EPS This Year

$-3.22

EPS Next Year

$-2.51

↓ 22.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CHEK EPS of $-3.22 for the current fiscal year, based on estimates from 1 analysts. The CHEK revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CHEK 股价预测由两类独立数据源支撑:来自 6 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CHEK 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

CHEK 的短期预测(明日)为 $3.16(+0.00%)。

Check-Cap Ltd. 在 NASDAQ 上市,代码 CHEK。CHEK 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CHEK 预测 · 8 个问题

根据 6 位华尔街分析师,CHEK 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $3.16,隐含约 +0.0% 的上行空间。

CHEK 目标价CHEK 分析师目标价CHEK 12个月目标价目标价 CHEK

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.